| Year of Transplant | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | ||
| Transplants | 948 | 893 | 922 | 977 | 1,083 | 1,054 | 1,099 | 1,185 | 1,407 | 1,406 | |
| Tx with Follow-up Immunosuppression Info | 671 | 627 | 665 | 735 | 804 | 828 | 883 | 982 | 1,121 | 1,145 | |
| Corticosteroids | Any in Category | 98.2% | 99.5% | 99.1% | 98.6% | 99.5% | 97.0% | 97.8% | 99.3% | 99.2% | 97.8% |
| Steroids | 98.2% | 99.5% | 99.1% | 98.6% | 99.5% | 97.0% | 97.8% | 99.3% | 99.2% | 97.8% | |
| Cyclosporine | Any in Category | 62.0% | 64.0% | 63.8% | 54.6% | 45.9% | 35.3% | 30.8% | 24.5% | 23.0% | 17.0% |
| Cyclosporin | 0.0% | 0.0% | 0.0% | 0.3% | 0.5% | 0.1% | 0.0% | 0.1% | 0.5% | 1.4% | |
| Sandimmmune | 8.0% | 6.5% | 4.7% | 4.2% | 5.0% | 2.5% | 2.7% | 1.3% | 1.8% | 1.7% | |
| Neoral | 53.8% | 57.4% | 58.6% | 48.2% | 34.0% | 26.0% | 20.7% | 17.5% | 14.9% | 9.3% | |
| Gengraf | 0.1% | 0.0% | 0.3% | 1.9% | 6.3% | 6.5% | 7.1% | 5.6% | 5.5% | 4.6% | |
| Eon | 0.0% | 0.0% | 0.2% | 0.0% | 0.1% | 0.1% | 0.2% | 0.0% | 0.3% | 0.1% | |
| Tacrolimus | Any in Category | 37.7% | 41.9% | 46.6% | 55.6% | 69.2% | 75.7% | 76.2% | 83.6% | 85.7% | 88.6% |
| Tacrolimus | 37.7% | 41.9% | 46.6% | 55.6% | 69.2% | 75.7% | 76.2% | 83.6% | 85.7% | 88.6% | |
| Antimetabolites | Any in Category | 88.5% | 93.0% | 91.4% | 94.3% | 90.8% | 88.8% | 87.7% | 88.7% | 91.8% | 92.4% |
| Mycophenolate Mofetil | 30.4% | 30.3% | 33.8% | 40.8% | 42.3% | 45.0% | 46.5% | 49.3% | 52.1% | 52.0% | |
| Mycophenolate Sodium | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.2% | 3.4% | 3.0% | |
| Azathioprine | 57.5% | 62.5% | 57.6% | 53.3% | 48.1% | 43.7% | 41.1% | 39.2% | 36.1% | 37.5% | |
| Leflunomide | 0.0% | 0.0% | 0.0% | 0.0% | 0.2% | 0.0% | 0.0% | 0.0% | 0.2% | 0.0% | |
| Cytoxan | 0.6% | 0.2% | 0.0% | 0.1% | 0.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| mTOR Inhibitors | Any in Category | 0.0% | 0.3% | 6.2% | 6.3% | 11.1% | 14.4% | 10.3% | 8.6% | 7.9% | 6.7% |
| Sirolimus | 0.0% | 0.2% | 5.9% | 6.3% | 11.1% | 14.4% | 10.3% | 8.6% | 7.9% | 6.7% | |
| Everolimus | 0.0% | 0.2% | 0.3% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |